Quick Answer: The top risk adjustment vendors for 2026 are best judged on one question: can the tool prove every diagnosis it submits? RAAPID leads with Neuro-Symbolic AI that links each HCC to MEAT-based evidence and supports two-way coding (adds and deletes), the pattern CMS and the OIG now expect. Navina is strong at physician-facing, point-of-care documentation. CodaMetrix automates high-volume coding with deep learning. With V28 fully live and the OIG flagging add-only chart reviews, defensible accuracy now matters more than raw code volume when you choose a vendor.
Key Takeaways
- Audit defensibility is the new buying criterion. The OIG’s February 2026 Medicare Advantage compliance guidance flags add-only chart reviews as a risk, so evaluate vendors on whether they can show clinical evidence for every code, not just find more codes [1].
- Two-way coding separates the field. Tools that add diagnoses but never remove unsupported ones now read as a compliance liability; the DOJ’s March 2026 Aetna settlement turned on exactly that pattern [2].
- RAAPID pairs Neuro-Symbolic AI with two-way retrospective review, prospective point-of-care support, and RADV audit management on one Clinical AI Platform.
- Navina focuses on physician adoption and point-of-care documentation [3].
- CodaMetrix automates high-volume medical record coding with deep learning; explainability during audits is the question to test [4][5].
What Health Plans Now Expect From Risk Adjustment Vendors
Medicare Advantage risk adjustment has reset. For years the job was framed as finding more diagnoses to lift risk scores. That era is closing. CMS finished its move to the V28 CMS-HCC model, finalized the exclusion of unlinked chart-review diagnoses, and restarted RADV audits on a quarterly cadence in February 2026 [6]. The OIG’s first Medicare Advantage compliance guidance update since 1999 names add-only chart reviews and in-home assessments as practices that draw scrutiny [1].
So the buying question changed. Health plans and healthcare providers no longer ask “which vendor captures the most?” They ask “which vendor can defend what we submit?” That shift, from capture to care, is the lens this comparison uses. For healthcare providers and the health plans that contract with them, an unsupported diagnosis sitting in the medical records is now a liability, not an asset. Defensible coding, where every diagnosis is encounter-linked, clinically evidenced, and auditable, is now the foundation of a sound risk adjustment program.
“When I audited charts for CMS, the codes that fell apart were the ones with no clinical story behind them. A past stroke coded as an acute stroke. A resolved cancer coded as active. The vendors worth your time in 2026 are the ones that make that evidence trail visible before an auditor ever asks.”
Wynda Clayton, MS, RHIT, CRC, Director of Risk Adjustment Coding and Compliance, RAAPID; former CMS RADV auditor
Risk Adjustment Vendor Comparison at a Glance
This risk adjustment vendor comparison weighs three approaches on the criteria that matter for 2026: how the technology reasons, where it fits in your workflow, and how well it holds up under audit. Healthcare organizations should weight coding accuracy and audit defensibility above raw capture.
| Vendor | Core technology | Best fit | Workflow coverage | Audit defensibility |
| RAAPID | Neuro-Symbolic AI (LLMs plus clinical knowledge graphs) | Health plans wanting one defensible source of truth for member risk | Prospective, retrospective (two-way), and RADV audit | Evidence trail linking every HCC to MEAT-based clinical documentation |
| Navina | AI clinical summaries for physicians | Provider groups prioritizing point-of-care adoption | Prospective documentation [3] | Strong at capture; test retrospective and audit depth |
| CodaMetrix | Deep-learning autonomous coding | High-volume medical record coding automation | Retrospective coding automation [4] | Evaluate explainability and reasoning trails for RADV [5] |
1. RAAPID: Neuro-Symbolic AI for Defensible Coding
RAAPID runs a Clinical AI Platform powered by Neuro-Symbolic AI, the only approach in this comparison that pairs large language models with a clinical knowledge graph to explain every code it suggests. Natural language processing reads the record and spots patterns. That is a real strength, and it is where most risk adjustment software stops. Neuro-Symbolic AI adds the reasoning layer: coding rules, clinical logic, and regulatory requirements encoded so each suggested HCC carries a trail back to specific MEAT-based evidence in the clinical note.
MEAT criteria (Monitor, Evaluate, Assess, Treat) is the documentation convention coders use to confirm a diagnosis is active and supported. When a CMS auditor questions a code, you can show which sentence in the medical records backs it and why the system flagged it. That is the difference between pattern matching and clinical reasoning.
Why it matters: the biggest red flag CMS sees today is a retrospective program that only adds diagnoses and never removes unsupported ones. RAAPID’s retrospective solution is two-way by design. It surfaces codes to add and codes to delete, which is the accountability pattern the OIG guidance and recent enforcement actions reward [1][2].
Three solutions run on the same platform:
- Prospective risk adjustment: the system builds pre-visit summaries from clinical and claims data so physicians walk into the encounter already knowing which suspected diagnoses to confirm and document at the point of care, which lifts both documentation quality and provider engagement.
- Retrospective risk adjustment: two-way chart review of the medical records that adds supported codes and removes unsupported ones, giving risk teams a single source of truth for member health status.
- RADV audit solution: AI-powered validation checks each code against MEAT criteria and links every HCC to the supporting clinical documentation, so audit responses draw from the same evidence the platform used to suggest the code.
RAAPID’s internal benchmarks: coding teams see a 60 to 80 percent productivity improvement, chart review runs about 8 to 12 minutes per chart, and coding accuracy reaches 92 percent out of the box and 98 percent or higher after human-in-the-loop review*. The platform is HITRUST certified and SOC 2 Type II compliant, with Azure-native deployment.
See how RAAPID builds a defensible evidence trail for every HCC. Request a demo.
2. Navina: Physician-Facing Point-of-Care Documentation
Navina is built for physician adoption, turning fragmented patient data into clean clinical summaries at the point of care [3]. Adoption drives program success, and Navina’s interface is designed so physicians use it rather than tolerate it. The platform pulls data from multiple sources and surfaces care gaps and suspected diagnoses during the encounter, supporting CMS-HCC and RxHCC models.
For healthcare organizations focused on prospective documentation and provider engagement, Navina offers genuine value. The open question for a buyer is coverage: if you also need high-volume retrospective review and structured RADV audit workflows, confirm whether you would pair Navina with another tool to handle those phases.
3. CodaMetrix: Autonomous High-Volume Coding
CodaMetrix applies deep learning to automate medical record coding across specialties, including Medicare Advantage risk adjustment [4]. Instead of static rules that need manual updates, its models learn from clinical and claims patterns and adapt as documentation changes. Neural networks let the system handle messy notes and non-standard terminology that rule-based engines miss, and EHR integration keeps it inside the existing workflows healthcare providers already use [5].
For provider organizations chasing efficiency on high-volume coding, CodaMetrix delivers real gains. The criterion to test is explainability. Deep-learning systems can struggle to produce the clear reasoning trail auditors now demand, which is the gap a Neuro-Symbolic approach is built to close. Ask any autonomous coding vendor to show the evidence behind a specific code in a live RADV scenario.
Autonomous Retrospective Risk Adjustment Solution
One platform. Every HCC validated. Revenue secured.
How to Compare Risk Adjustment Vendors in 2026
Score each vendor against the workflows you actually run and the audits you actually face, not against generic feature lists. Most health plans and healthcare organizations need coverage across prospective documentation, retrospective review, and audit readiness rather than point solutions stitched together by hand.
Use these steps:
- Define requirements across all three phases. Map where documentation gaps cost you in prospective workflows, how much retrospective opportunity sits uncaptured, and where your audit readiness is thin.
- Demand reasoning, not just results. Ask each vendor to prove the AI’s reasoning on a specific code. A tool that cannot explain a suggestion will struggle when an auditor asks the same question.
- Check two-way coding. Confirm the platform removes unsupported codes, not just adds new ones. Add-only programs are now a compliance exposure [1][2].
- Verify the evidence trail. Every diagnosis should link to MEAT-based clinical documentation in the medical records a reviewer can open.
- Check references by size and market. Ask peer health plans about adoption rates, coding accuracy, and real audit outcomes, not satisfaction scores.
If your shortlist is organized by company rather than tool, our guide to risk adjustment companies breaks down vendors at the organization level. If you are evaluating the technology category itself, see our overview of risk adjustment software.
Why RAAPID’s Approach Holds Up
Across these risk adjustment vendors, RAAPID stands apart by treating risk adjustment as a compliance and care discipline, not a revenue engine. The Clinical AI Platform uses Neuro-Symbolic AI to give accuracy, speed, and explainability together, and it handles prospective, retrospective, and audit work at the same depth.
That delivers what health plans need now: one defensible source of truth for member risk. Codes surfaced in the prospective workflow already carry evidence. Retrospective review holds the same standard, two ways. Audit responses pull from the same reasoning that suggested the code in the first place. With V28 live and RADV audits running again, that consistency is what turns a stressful audit into a controlled, predictable process [6].
The right vendor is a partner in sustainable performance: accurate documentation, defensible coding, and better continuity of patient care, in a way regulators, auditors, and clinicians all trust.
Talk to RAAPID about defensible risk adjustment across all three workflows. Book a demo.
Frequently Asked Questions
RAAPID offers the strongest audit defense in this comparison through Neuro-Symbolic AI that links every HCC to specific MEAT-based evidence in the clinical record. Because the platform can show which documentation supports each code, audit responses rest on a visible evidence trail rather than pattern matching that is hard to defend when CMS auditors question a diagnosis.
Navina is built around physician adoption. It turns scattered patient data into clean clinical summaries at the point of care and surfaces care gaps during the visit, supporting CMS-HCC and RxHCC models [3]. Its strength is prospective documentation and provider engagement; buyers needing heavy retrospective review or audit workflows should confirm coverage for those phases.
Autonomous coding delivers real efficiency on high-volume work, and CodaMetrix improves as its deep-learning models learn from clinical patterns [4]. The question for RADV is explainability: deep-learning systems can struggle to produce clear reasoning trails [5]. Pair automation with human review for complex cases, and test whether the vendor can explain any specific code.
Two-way coding means a tool both adds supported diagnoses and removes unsupported ones. CMS and the OIG now treat add-only programs that ignore codes needing deletion as evidence of intent to inflate payments; the DOJ’s March 2026 Aetna settlement turned on that pattern [2]. A two-way vendor protects accuracy and audit readiness at once.
With V28 fully implemented and unlinked chart-review diagnoses excluded, health plans should prioritize defensibility: encounter-linked documentation, an evidence trail for every code, two-way coding, coding accuracy that holds after review, and consistent coverage across prospective, retrospective, and audit workflows [6]. Raw code volume matters less than whether each diagnosis can survive a RADV review.
Transform your coding practice into defensible RAF growth with Novel Clinical AI
Sources
Wynda Clayton, MS, RHIT, CRC
Director of Risk Adjustment Coding & Compliance, RAAPID
Wynda Clayton, MS, RHIT, CRC, is Director of Risk Adjustment Coding and Compliance at RAAPID and a former CMS RADV auditor. She advises health plans on defensible coding, MEAT-based documentation, and RADV audit readiness. \ Internal RAAPID benchmark. Coding accuracy figures distinguish raw out-of-the-box AI output (92%) from final quality accuracy after human-in-the-loop review (98%+).*
